Nuvectra to Present at Two Upcoming Investor Conferences

May 17, 2018

PLANO, Texas, May 17, 2018 (GLOBE NEWSWIRE) -- Nuvectra Corporation (NASDAQ:NVTR), a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at two upcoming investor conferences in June 2018.

Event: Jefferies 2018 Global Healthcare Conference Date: Tuesday, June 5, 2018 Time: 10:30 a.m. ET Location: The Grand Hyatt, New York Event: JMP Securities Life Sciences Conference Date: Wednesday, June 20, 2018 Time: 2:30 p.m. ET Location: St. Regis Hotel, New York

A webcast of each presentation will be available by visiting the investor relations section of Nuvectra’s website at www.nuvectramed.com. A webcast replay of the presentation will be available for 90 days.

Investors attending the conference who would like to schedule a one-on-one meeting with Nuvectra management may do so by contacting their Jefferies or JMP Securities representative, or Brian Johnston of The Ruth Group at bjohnston@theruthgroup.com.

About Nuvectra Corporation

NuvectraTM is a neurostimulation company committed to helping physicians improve the lives of people with chronic conditions. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson’s Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.

Company Contacts: Investor Contacts: Nuvectra Corporation The Ruth Group Walter Berger, COO & CFO Tram Bui / Brian Johnston (214) 474-3102 (646) 536-7035 / 7028 wberger@nuvectramed.com investors@nuvectramed.com

Update hourly